80 FR 22555 - Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 77 (April 22, 2015)

Page Range		22555-22555
FR Document		2015-09331

Federal Register, Volume 80 Issue 77 (Wednesday, April 22, 2015)

[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Page 22555]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-09331]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before June 22, 2015.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
January 29, 2015, Noramco, Inc., 500 Swedes Landing Road, Wilmington, 
Delaware 19801-4417 applied to be registered as a bulk manufacturer of 
the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Morphine-N-oxide (9307)....................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Phenylacetone (8501).......................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, powdered (9639).....................  II
Opium, granulated (9640)...................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers.

    Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-09331 Filed 4-21-15; 8:45 am]
 BILLING CODE 4410-09-P

Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 22555

Controlled substance Schedule February 10, 2015, Stepan Company, In accordance with 21 CFR
Natural Products Department, 100 W. 1301.33(a), this is notice that on January
Amphetamine (1100) .................... II Hunter Avenue, Maywood, New Jersey 29, 2015, Noramco, Inc., 500 Swedes
Methylphenidate (1724) ................ II 07607 applied to be registered as a bulk Landing Road, Wilmington, Delaware
Oxycodone (9143) ........................ II manufacturer of the following basic 19801–4417 applied to be registered as
Hydromorphone (9150) ................ II
classes of controlled substances: a bulk manufacturer of the following
Hydrocodone (9193) ..................... II
Fentanyl (9801) ............................ II basic classes of controlled substances:
Controlled substance Schedule
The company plans to import the Controlled substance Schedule
Cocaine (9041) ............................. II
listed controlled substances for clinical Ecgonine (9180) ........................... II Codeine-N-oxide (9053) ............... I
trials, research and analytical purposes. Dihydromorphine (9145) ............... I
Dated: April 14, 2015. The company plans to manufacture Morphine-N-oxide (9307) ............. I
Joseph T. Rannazzisi, the listed controlled substances in bulk Amphetamine (1100) .................... II
for distribution to its customer. Methylphenidate (1724) ................ II
Deputy Assistant Administrator. Phenylacetone (8501) .................. II
[FR Doc. 2015–09339 Filed 4–21–15; 8:45 am] Dated: April 14, 2015. Codeine (9050) ............................. II
BILLING CODE 4410–09–P Joseph T. Rannazzisi, Dihydrocodeine (9120) ................. II
Deputy Assistant Administrator. Oxycodone (9143) ........................ II
[FR Doc. 2015–09327 Filed 4–21–15; 8:45 am] Hydromorphone (9150) ................ II
DEPARTMENT OF JUSTICE Hydrocodone (9193) ..................... II
BILLING CODE 4410–09–P
Morphine (9300) ........................... II
Drug Enforcement Administration Oripavine (9330) ........................... II
Thebaine (9333) ........................... II
[Docket No. DEA–392] DEPARTMENT OF JUSTICE Opium extracts (9610) .................. II
Opium fluid extract (9620) ............ II
Bulk Manufacturer of Controlled Drug Enforcement Administration Opium tincture (9630) .................. II
Substances Application: Stepan [Docket No. DEA–392] Opium, powdered (9639) ............. II
Company Opium, granulated (9640) ............ II
Bulk Manufacturer of Controlled Oxymorphone (9652) ................... II
ACTION: Notice of application. Substances Application: Noramco, Inc.
Noroxymorphone (9668) .............. II
Tapentadol (9780) ........................ II
DATES: Registered bulk manufacturers of ACTION: Notice of application.
the affected basic classes, and The company plans to manufacture
applicants therefore, may file written DATES: Registered bulk manufacturers of the above-listed controlled substances
comments on or objections to the the affected basic classes, and in bulk for distribution to its customers.
issuance of the proposed registration in applicants therefore, may file written Dated: April 14, 2015.
accordance with 21 CFR 1301.33(a) on comments on or objections to the Joseph T. Rannazzisi,
or before June 22, 2015. issuance of the proposed registration in Deputy Assistant Administrator.
ADDRESSES: Written comments should accordance with 21 CFR 1301.33(a) on [FR Doc. 2015–09331 Filed 4–21–15; 8:45 am]
be sent to: Drug Enforcement or before June 22, 2015.
BILLING CODE 4410–09–P
Administration, Attention: DEA Federal ADDRESSES: Written comments should
Register Representative/ODXL, 8701 be sent to: Drug Enforcement
Morrissette Drive, Springfield, Virginia Administration, Attention: DEA Federal DEPARTMENT OF JUSTICE
22152. Request for hearings should be Register Representative/ODW, 8701
sent to: Drug Enforcement Morrissette Drive, Springfield, Virginia Drug Enforcement Administration
Administration, Attention: Hearing 22152. Request for hearings should be [Docket No. DEA–392]
Clerk/LJ, 8701 Morrissette Drive, sent to: Drug Enforcement
Springfield, Virginia 22152. Administration, Attention: Hearing Bulk Manufacturer of Controlled
SUPPLEMENTARY INFORMATION: The Clerk/LJ, 8701 Morrissette Drive, Substances Application: Cambrex
Attorney General has delegated his Springfield, Virginia 22152. Charles City
authority under the Controlled SUPPLEMENTARY INFORMATION: The
Substances Act to the Administrator of Attorney General has delegated his ACTION: Notice of application.
the Drug Enforcement Administration authority under the Controlled
(DEA), 28 CFR 0.100(b). Authority to Substances Act to the Administrator of DATES: Registered bulk manufacturers of
exercise all necessary functions with the Drug Enforcement Administration the affected basic classes, and
respect to the promulgation and (DEA), 28 CFR 0.100(b). Authority to applicants therefore, may file written
implementation of 21 CFR part 1301, exercise all necessary functions with comments on or objections to the
incident to the registration of respect to the promulgation and issuance of the proposed registration in
manufacturers, distributors, dispensers, implementation of 21 CFR part 1301, accordance with 21 CFR 1301.33(a) on
importers, and exporters of controlled incident to the registration of or before June 22, 2015.
substances (other than final orders in manufacturers, distributors, dispensers, ADDRESSES: Written comments should
connection with suspension, denial, or importers, and exporters of controlled be sent to: Drug Enforcement
asabaliauskas on DSK5VPTVN1PROD with NOTICES

revocation of registration) has been substances (other than final orders in Administration, Attention: DEA Federal
redelegated to the Deputy Assistant connection with suspension, denial, or Register Representative/ODXL, 8701
Administrator of the DEA Office of revocation of registration) has been Morrissette Drive, Springfield, Virginia
Diversion Control (‘‘Deputy Assistant redelegated to the Deputy Assistant 22152. Request for hearings should be
Administrator’’) pursuant to section 7 of Administrator of the DEA Office of sent to: Drug Enforcement
28 CFR part 0, appendix to subpart R. Diversion Control (‘‘Deputy Assistant Administration, Attention: Hearing
In accordance with 21 CFR Administrator’’) pursuant to section 7 of Clerk/LJ, 8701 Morrissette Drive,
1301.33(a), this is notice that on 28 CFR part 0, appendix to subpart R. Springfield, Virginia 22152.

VerDate Sep<11>2014 18:00 Apr 21, 2015 Jkt 235001 PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\22APN1.SGM 22APN1

Document Created: 2015-12-16 08:27:40
Document Modified: 2015-12-16 08:27:40

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of application.
Dates		Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 22, 2015.
FR Citation		80 FR 22555

80 FR 22555 - Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 80, Issue 77 (April 22, 2015)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration